Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy
Clinical trial NCT03802214 · TERMINATED
Trial details
- NCT number
- NCT03802214
- Sponsor
- Stanford University
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-29
- Primary completion
- 2020-12-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.